Inducible Urticaria
📧 Sign up to get email alerts when something new happens for Inducible Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of EDP-978 in healthy adu…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of remibrutinib (LOU064) in chronic urticaria, including chronic spontaneous …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines [Phase 3]
Phase 3 trial evaluating remibrutinib vs placebo for adults with chronic inducible urticaria not controlled by H1-antihistamines; the study …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU) [Phase 2]
BLU-808 is being studied in a Phase 2 trial for Chronic Inducible Urticaria and Chronic Spontaneous Urticaria, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria [Phase 1]
A Phase 1 study of GTX-B001 in healthy subjects and individuals with chronic inducible urticaria is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Deep Phenotyping of CIndU
A clinical trial update from the Centre for Human Drug Research (Netherlands) recruiting participants to deeply phenotype chronic inducible …